Unilever CEO: The health business is expected to be a contributor to growth in the next few quarters; growth will exceed market levels in the second half of 2027.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.